TTS Young Investigator Awards

tts medalThe Young Investigator Awards are given to recipients who have submitted abstracts to the International Congress of The Transplantation Society and received the highest scores from an international panel of reviewers.

Select a year to view recipient details:

2022

Young Investigator Award

Eliminating second warm ischemia in order to address the organ shortage, increase transplant longevity, and enable minimally invasive kidney transplantation: ex-vivo validation of a kidney anastomosis facilitation and cooling device developed via the Biodesign process
Keith S. Hansen, United States
University of California, San Francisco

mTOR inhibitors promote highly functional T cell immunity in kidney transplant recipients vaccinated against COVID-19
Griffith B. Perkins, Australia
University of Adelaide, Athelstone

Real-life tacrolimus levels are associated with biopsy-proven acute rejection after the first year post-kidney transplantation
Soufian Meziyerh, The Netherlands
Leiden University Medical Center, Leiden

Investigating iron limitation in tolerance and regulatory T cells' dynamic iron requirements
Marie Sion, United Kingdom
University of Oxford, Oxford

Co-transplantation with adipose tissue-derived stem cells improves engraftment of transplanted hepatocytes
Hiroki Yamana, Japan
Tohoku University Hospital, Sendai

Every 2-month belatacept maintenance therapy in kidney transplant recipients: 3-year follow-up of a randomized, non-inferiority trial
Aileen C. Johnson, United States
Emory Transplant Center, Atlanta, Georgia

2018

tts2018 yisa

The recipients of the TTS Young Investigator Scientific Awards submitted abstracts to the 2018 Congress and received the highest scores from an international panel of reviewers.

  • Rebeca Arroyo Hornero, United Kingdom
    Co-Stimulatory Modulation of Human Regulatory T cells for Enhanced Immunotherapy
  • Yarl Balachandran, United States
    Delineation of the Viral and Host Cell Genomic Alterations in EBV-positive PTLD
  • Florencia Bonisconti, Argentina
    Clinical Utility of a Modified qRT-PCR for Trypa- nosoma Cruzi Detection in Transplant Patients
  • Xiaoyong Chen, People's Republic of China
    Characterization of a CD23+CD43+ Regulatory B Cell Subset in Human that Induced by Mesenchymal Stem Cells
  • Aravind Cherukuri, United States
    Prospective Multicenter Validation of Human Transitional B cell Cytokines as a Predictive Biomarker in Renal Transplantation
  • Fang Kuan Chiou, Singapore
    Poorer Long-Term Survival Associated with Monomorphic Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation in Children
  • Dominik Chittka United States
    DSA plus TCMR Leads to Poor Outcomes in Renal Allograft Recipients and this is Markedly Exacerbated by Non-Adherence
  • Helong Dai, People's Republic of China
    Distal Abdominal Aorta Could Serve as an Out-flow Tract for en Bloc Kidney Transplantation from Infant Donors with Extremely Low Body Weight
  • Nicole De La Mata, Australia
    Stroke Mortality in Kidney Transplant Recipients: A Retrospective Population-Based Cohort Study using Data Linkage
  • Reinier de Vries, United States
    Extending the Human Liver Preservation Time for Transplantation by Supercooling
  • Su Kah Goh, Australia
    Donor-Specific Cell-Free DNA as an Emerging Biomarker of Organ Rejection after Liver Transplantation
  • Christian Heim, Germany
    Blockade of Tyrosine Kinases as Preventive Strategy Against Cardiac Allograft Vasculopathy in a Murine Aortic Transplant Model
  • Charlotte Lee, United Kingdom
    The Anti-Inflammatory Effect of Alpha-1 Antitrypsin in Hepatocyte Transplantation
  • Xiaoqian Ma, People's Republic of China
    Cord Blood Derived Regulatory Macrophages (Mreg) – An Alternative Source for Mreg-based Cell Therapy in Transplantation
  • Berenice Mbiribindi, United States
    NK Cell Recognition of Peptides Encoded by EBV Latent Cycle Proteins
  • Hiroyuki Ogasawara, Japan
    A Comparison of the Transplant Efficiency between Intraportal and Intrasplenic Procedures in Hepatocyte Transplantation
  • Brenda Rosales, Australia
    Cancer Mortality in Transplant Recipients in Australia and New Zealand: A National Cohort Study from 1980 to 2013
  • Akhil Sharma, United States
    Pro-inflammatory B Cells Predict Progressive Minimal Early Renal Allograft Inflammation Which Is Associated With Poor Graft Outcomes
  • Nicole Shockcor, United States
    End Stage Renal Disease as a Complication of Face Transplant
  • Ashley Suah, United States
    Acquired Resistance to Transplantation Tolerance as a Result of Prior Pregnancy Requires B Cells
  • Patrick Trotter, United Kingdom
    Transplantation of Kidneys from DCD and DBD Donors who Died after Ligature Asphyxiation: the UK Experience
  • Marieke van der Zwan, The Netherlands
    Efficacy of Rabbit Anti-Thymocyte Globulin Therapy for Severe Acute Rejection in Kidney Transplant Patients using Calcineurin Inhibitor and Mycophenolate Mofetil based ImmunosuppressiveTherapy
  • Karen Waller, Australia
    Incidence, Prevalence and Residual Infection Risk of HIV in Increased Risk Groups Presenting as Potential Organ Donors in Australia; A Systematic Review and Meta-Analysis
  • Casey Ward, United States
    Reversal of Diabetes and Preservation of Pancreatic Islet Grafts in the Extrahepatic Space with Novel Parathyroid Gland Co-Transplantation
  • Cheng Yang, People's Republic of China
    Prediction of Renal Allograft Chronic Rejection using a Model Based on Contrast Enhanced Ultrasonography
  • Yuanfei Zhao, Australia
    In-vivo Costimulation-Blockade induced Foxp3 Tregs from DEREG Mice with Neonatal Islet Cell Cluster Tolerant Xenografts Exist Memory Tregs Phenotype
2016
  • PENELOPE ALLEN, Australia
    The impact of recurrent glomerulonephritis after kidney transplantation in the era of contemporary maintenance immunosuppression
  • VAISHNAVI CALISA, Australia
    The relative costs and health benefits of an age-matched deceased donor allocation algorithm compared to current practice
  • ARAVIND CHERUKURI, United States
    Early de novo DSA with T Cell Mediated Rejection (TCMR) is Associated with Allograft Dysfunction with Chronic Injury
  • JASON DAVIS, Unites States
    Changes in liver allograft steatosis and its impact on early graft function and long term survival
  • DENIS EFIMOV, Belarus
    DAMP-associated preservation injury and complications after liver transplantation: proof of concept
  • SHAIMAA ELKHOLY, Egypt
    Predictors of Mortality In Living Donor Liver Transplantation
  • JIANING FU, United States
    Generation of naïve donor-derived lymphocytes from graft-resident lymphoid progenitors after human intestinal transplantation
  • BARBARA KERN, Australia,
    Nonalcoholic Steatohepatitis as Indication for Liver Transplantation in Europe. Clinical Analysis of over 37.000 Patients
  • QIANG LIU, United States
    Triglyceride exportation in the preservation of discarded steatotic human livers using 24 hours ex-vivo normothermic machine perfusion
  • DAVID NASRALLA, Unites Kingdom
    A Multicentre Randomised Controlled Trial to Compare the Efficacy of Normothermic Machine Perfusion with Static Cold Storage in Human Liver Transplantation: Early Outcomes
  • KEVIN TAK-PAN NG, Hong Kong
    Up-regulation of GSTA2 at early-phase after liver transplantation increases the risk of late-phase hepatocellular carcinoma recurrence
  • THOMAS SCHACHTNER, Germany
    Kinetics of CMV-specific T-cells From Pre-to-Posttransplantation Predict Outcomes in CMV-seronegative Kidney Transplant Recipients
  • OSCAR SERRANO, United States
    Defining the tipping point in surgical performance in laparoscopic donor nephrectomy during abdominal transplant surgery fellowship: a learning curve analysis.
  • RASHMI SHINGDE, Australia
    Trojan Kidneys: Unexpected Donor-Derived Viral Transmission in Kidney Transplant Recipients – a Systematic Review
  • UMANG THAKKAR, India
    Stem cell therapy as an emerging modality for post-traumatic paraplegia and for renal parenchymal diseases
  • MIRJAM TIELEN, Netherlands
    Importance of Early Medication Adherence for Long-Term Graft Survival: A Prospective, Single-Centre Cohort Study
  • THOMAS VANHOVE, Belgium
    Tubulointerstitial expression of connective tissue growth factor in renal allograft protocol biopsies at 3 months predicts interstitial fibrosis at 5 years
  • GEORGIOS VRAKAS, United Kingdom
    De Novo Donor-Specific HLA Antibodies after Combined Intestinal and Vascularized Composite Allotransplantation
  • JOHANNES WEDEL, United States
    DEPTOR modulates alloimmunity by increasing regulatory T cell function and stabilizing Foxp3 expression
  • CHENG YANG, China
    Cyclic Helix B Peptide Inhibits Ischemia Reperfusion-induced Renal Fibrosis via the PI3K/Akt/FoxO3a Pathway
  • WAI HO OSCAR YEUNG, Hong Kong
    Dysregulation of transforming growth factor beta receptor III induces tumor promoting macrophages via complement C3a in Hepatocellular Carcinoma recurrence after liver transplantation
2014

The Young Investigator Awards are given to recipients who have submitted abstracts to the International Congress of The Transplantation Society and received the highest scores from an international panel of reviewers. The award has been made possible by the generous support of Astellas Pharma Inc.

  • Deyaa El Deen Morsy
    Lymphocytes Can Play The Trojan-Horse Role in Polyoma BKV Infection
  • Liang Wei
    The MicroRNA miR-182 Alters CD4+ T Cell Responses Post-Transplant
  • Sharmila Ramessur
    The Role of Spleen Tyrosine Kinase in Acute Renal Allograft Rejection in the Rat
  • Carolina Moore
    Clonal Composition and Specificity of Graft Infiltrating B Cells in Human Cardiac Allograft Vasculopathy
  • Fadi Issa
    Evaluation and Optimisation of Non-Autologous Human Regulatory T Cell Therapy for Transplantation
  • Seiichi Shimizu
    Association ofFc-gamma Receptor Gene Polymorphisms With Susceptibility to Bloodstream Infections After Liver Transplantation
  • Masaaki Zaitsu
    Anti-CD28 Antagonism Using a Monovalent Fab Antibody for the Prolongation of Human Skin Allograft Survival
  • Toshihito Hirai
    A Novel Approach Inducing Transplant Tolerance By Activated Invariant Natural Killer T Cells With Co Stimulatory Blockade
  • Katrien De Vusser
    Intrarenal Telomere Length and Intrarenal Arteriosclerosis in Pretransplant Kidney Biopsies
  • Silke Roedder
    A 17 Gene Blood Assay (kSORT) for Diagnosis and Prediction of Acute Renal Transplant Rejection: Results of the Multicenter AART Study
  • Karolina M. Burghardt
    Proposed Listing Indications for Pediatric Intestinal Transplant in the New Era of Specialized Care for Intestinal Failure
  • Goutham Kumar
    Predictors For Better Graft Survival After Intestinal and Multivisceral Transplantation
  • Yuk Man (Kevin) Lei
    The Microbiota Promotes Skin Allograft Rejection
  • Yanbao Xiong
    Treg Require Transcription Factor T-bet to Traffic to Draining Lymph Nodes and Prolong Islet Allograft Survival
  • S. Keshwani
    Pre-Transplant T-Cell Subtype Assessment as a Predictive Tool for CMV Viremia After Transplant
  • Nissreen Elfadawy
    The Clinical Relevance ofHLA Cw, DQ and DP Mismatches Among The Zero HLA A, B and DR Mismatched Deceased Donor (DD) Kidney Transplant Population
  • Esme Dijke
    Pediatric Thymic Tissue as a Novel Source for the Expansion of Stable Regulatory T Cells for Cellular Therapy
  • Aunemarie Weissenbacher
    VCA at Innsbruck Medical University - An Update 14 Years After the First Hand Transplantation
  • Angelo Alberto Leto Barone
    Either Abatacept or Belatacept in Combination With Donor Bone Marrow Infusion Induces Immune Tolerance Across a Full MHC Barrier in a Translational Large Animal Vascularized Composite Allotransplantation Model
  • Jorge Roque Espinosa
    CD57+CD4 T Cells and Belatacept Resistant Rejection
  • Makoto Tonsho
    Successful Tolerance Induction of Lung Allografts in Non-Human Primates
  • Shruti D. Dave
    Mesenchymal Stem Cells Induced In Vitro Generation of Antigen Specific Regulatory T-Cells Containing CD4+CD8+ Population: A Cell-Based Therapy To Promote Transplantation Tolerance
2012

The Young Investigator Awards are given to recipients who have submitted abstracts to the International Congress of The Transplantation Society and received the highest scores from an international panel of reviewers. The award has been made possible by the generous support of Astellas Pharma Inc.

Esme

Esmé Dijke, Canada

Expansion of Highly Suppressive FOXP3+ Regulatory T Cells from Pediatric Thymic Tissue

DR Vivek Kute

Vivek Kute, India

Novel Strategy for Tolerance Induction in Living Donor Renal Transplantation

giselemeinerz

Gisele Meinerz, Brazil

Increasing Incidence of Tuberculosis after Renal Transplantation in a Brazilian Center

Miwas-photo

Miwa Morita, USA

Liver Stromal Cells Contribute to Liver Transplant Tolerance: Involved Cellular and Molecular Mechanisms

poirier

Nicolas Poirier, France

Preclinical Evaluation of FR104, An Antagonist Anti-CD28 Monovalent Fab’antibody, in DTH and Kidney Transplant Primates Models

thomas rogerson

Thomas Rogerson, Australia

Tests for Latent Tuberculosis in Potential Transplant Recipients: A Systematic Review

Photo-Moritz-Schmelzle-II

Moritz Schmelzle, USA

Increased Plasma Levels of CD133+ Microparticles Bearing Ectonucleotidases Are Noted in Acute Liver Failure in Patients and in Experimental Mouse Models

Schmidt-Tina

Tina Schmidt, Germany

Comparative Analysis of Assays for Detection of Cellular Immunity Towards CMV and M. Tuberculosis in Samples from Deceased Donors

Sharif

Adnan Sharif, United Kingdom

One-Year Biopsy Data of Antibody-Incompatible Kidney Transplantation and Correlation with Medium-to-Long Term Risk of Allograft Loss – a Prospective Analysis

Simo-Syrjala

Simo Syrjälä, Finland

Ang1 Reduces Ischemia-Reperfusion Injury–Induced Microvascular Dysfunction and Chronic Rejection in
Rat Cardiac Allografts

Supported through an unrestricted educational grand from: Astellas

2010

The Young Investigator Awards are given to recipients who have submitted abstracts to the International Congress of The Transplantation Society and received the highest scores from an international panel of reviewers. The award has been made possible by the generous support of Astellas Pharma Inc.

afaneh

Cheguevara Afaneh, USA

Differential regulation of positive or negative costimulatory molecules during acute rejection of human renal allografts

Russell-Hodgson

Russell Hodgson, Australia

Prolonged xenograft survival induced by ICOS-IG Is associated with increased Foxp3+ cells

Khan

Faisal Khan, Canada

Genomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-vs-host disease, and rare in nasal mucosa

Li

Li Li, USA

A highly specific novel 3 gene-set can non-invasively predict operational renal allograft tolerance

Luiz-Lisboa

Luiz Lisboa, Canada

In vivo viral microRNA profiling in a large cohort of transplant patients with CMV disease

Markey

Kate Markey, Australia

GVHD-associated immune suppression is the result of an intrinsic defect in MHC class II antigen presentation within donor DC

Susumu-Shibasaki

Susumu Shibasaki, Japan

A single infusion of the ex-vivo generated immunoregulatory dendritic cells under a novel agent, NK026680 markedly prolongs cardiac allograft survival

Tokodai

Kazuaki Tokodai, Japan

Interruption of a cross-talk between the complement and coagulation cascades improves early outcomes after intraportal islet transplantation

Trydzenskaya

Hanna Trydzenskaya, Germany

New protocol of BKV-specific T cell analysis allows for improved assessment of phenotypic and functional characteristics of BKV-specific immunity

Laura-Wozniak

Laura Wozniak, USA

Validation of a transcriptional profile of tolerance in pediatric liver transplant recipients

Supported through an unrestricted educational grand from: Astellas

2008

SHEUNG-TAT-FAN-Photo

TTS • Genzyme Award
for Innovation in Surgery and Technology

Sheung-Tat Fan, Hong Kong
MARTI-MANYALICH-Photo

TTS • Genzyme Award
for Education and Training in Transplantation

Marti Manyalich, Spain
RUTGER-PLOEG-Photo

TTS • Novartis Award for Outstanding Investigator Driven Clinical Trial 

Rutger Ploeg, The Netherlands
Ulf-Meier-Kriesche-Labcoat-071406

TTS • Novartis Award
for Outstanding Contribution to the Evidence Base for Transplantation

Herwig-Ulf Meier-Kriesche, USA
JEAN-APUL-SOULILLOU-Photo

TTS • Roche Award
for Outstanding Achievement Transplantation Science (Basic) 

Jean-Paul Soulillou, France
BJn-photo

TTS • Roche Award
for Outstanding Achievement Transplantation Science (Clinical)      

Brian Nankivell, Australia
JAMES-SOUTHARD-Photo

TTS • Roche Award
for Excellence in Translational Science       

James Southard, USA
RAFAEL-MATESANZ

TTS • Roche Award
for Worldwide Impact in Transplantation

Rafael Matesanz, Spain
JAY-A

TTS • Roche Award
for Transplant Infectious Disease    

Jay A. Fishman, USA
2006

The Young Investigator Awards are given to recipients who have submitted abstracts to the International Congress of The Transplantation Society and received the highest scores from an international panel of reviewers. The award has been made possible by the generous support of Astellas Pharma Inc. since 1994. The recipients in 2006 during the 1st World Transplant Congress:

Ran Tao


LIGATION OF BTLA ON EFFECTOR T CELLS BY HVEM EXPRESSED BY REGULATORY T CELLS (TREGS) CONTRAOLS THE SUPPRESSIVE FUNCTIONS OF TREGS IN VITRO AND IN VIVO

Kerem H. Bortecen


LOCAL ADMINISTRATION OF IN VIVO GENERATED TREG PREVENT THE REJECTION OF ISLET ALLOGRAFTS

Gang Feng


EX VIVO GENERATION OF REGULATORY T CELLS THAT PREVENT SKIN AND ISLET ALLOGRAFT REJECTION: A NOVEL ROLE FOR IFN-T.

Kerem H. Bortecen


LOCAL ADMINISTRATION OF IN VIVO GENERATED TREG PREVENT THE REJECTION OF ISLET ALLOGRAFTS

Martin Bodingbauer


PROPHYLACTIC BISPHOSPHONATE TREATMENT PREVENTS BONE FRACTURES AFTER LIVER TRANSPLANTATION

Amy M. Dowden


BONE MORPHOGENETIC PROTEIN 4 (BMP-4) PROMOTES IN VIVO DIFFERENTIATION OF EMBRYONIC STEM CELLS (ESC) INTO LYMPHOID AND MYELOID HEMATOPOIETIC CELLS

Shin Itakura


MESENCHYMAL STEM CELLS FACILITATE INDUCTION OF MIXED CHIMERISM AND ISLET ALLOGRAFT TOLERANCE WITHOUT GVHD IN THE RAT

Matthew J. Vitalone


EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN CHRONIC ALLOGRAFT NEPHROPATHY (CAN)

Jose Caballero-Corbalan


NO BENEFICIAL EFFECT OF THE TWO LAYER METHOD (PFC-UW) COMPARED WITH TRANSPORTATION IN UW ALONE ON THE OUTCOME OF HUMAN ISLET ISOLATION AND TRANSPLANTATION: A REPORT ON 214 HUMAN PANCREASES

Iris Lee


RETROVIRALLY-TRANSDUCED FOXP3+T CELLS PROMOTE PERMANENT SURVIVAL OF FULLY MHC-MISMATCHED CARDIAC ALLOGRAFTS IN IMMUNOCOMPETENT HOSTS

Qiquan Sun


C4D-POSITIVE ACUTE REJECTION AT DIFFERENT TIME PERIODS AFTER RENAL TRANSPLANTATION: DIFFERENT CLINICO-HISTOPATHOLOGICAL MANIFESTATIONS REQUIRE DIFFERENT TREATMENT STRATEGIES

Supported through an unrestricted educational grand from: Astellas

2004

The Young Investigator Awards are given to recipients who have submitted abstracts to the International Congress of The Transplantation Society and received the highest scores from an international panel of reviewers. The award has been made possible by the generous support of Astellas Pharma Inc.

Koji Yazawa, BOSTON, MA , UNITED STATES

NEITHER COMPLEMENT INHIBITION NOR DEPLETION OF NATURAL ANTIBODY IS REQUIRED TO AVOID HYPERACUTE OR ACCELERATED ACUTE REJECTION FOLLOW-ING GALT-KO PIG-TO-BABOON RENAL TRANSPLANTATION

Tun Jie, MINNEAPOLIS, UNITED STATES

PANCREATIC ISLET XENOTRANSPLANTS RESTORE NORMOGLYCEMIA AND INSULIN INDEPENDENCE IN IMMUNOSUPPRESSED NON-HUMAN PRIMATES

Svjetlan Boskovic, BOSTON, MA, UNITED STATES

LONG TERM (>5 YEARS) OBSERVATIONS IN RENAL ALLOGRAFT RECIPIENTS TREATED WITH CHIMERISM-INDUCING NONMYELOABLATIVE REGIMEN WITH CD154 BLOCKADE

Michelle Solomon, LA JOLLA, UNITED STATES

CONSTITUTIVE EXPRESSION OF SUPPRESSOR OF CYTOKINE SIGNALING-1 (SOCS-1) IN PANCREATIC ISLETS DELAYS ISLET ALLOGRAFT REJECTION

Mona Doshi, IOWA CITY, IA, UNITED STATES

SHORT AND LONG TERM OUTCOME OF LIVER TRANSPLANTS FROM DONORS DECEASED AFTER CARDIAC DEATH (DCD)

Angela Webster, WESTMEAD, NSW, AUSTRALIA

INCIDENCE, RISK AND PREDICTORS OF CANCER AFTER RENAL TRANSPLANTATION; ANANALYSIS OF ANZDATA, THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY

Maren Ruhnke, KIEL, GERMANY

NORMALIZATION OF BLOOD GLUCOSE BY HUMAN MONOCYTE-DERIVED PANCREATIC ISLET-LIKE||CELLS IN STREPTOZOTOZIN DIABETIC MICE||-PERSPECTIVES FOR AUTOLOGOUS CELL THERAPY

Hao Wang, LONDON, CANADA

INHIBITION OF TERMINAL COMPLEMENT WITH A FUNCTIONALLY BLOCKING ANTI-C5 MONOCLONAL ANTIBODY PREVENTS ACUTE HUMORAL REJECTION AND ACCELERATED HUMORAL REJECTION IN A MOUSE CARDIAC ALLOGRAFT TRANSPLANTATION MODEL

Constantino Fondevila, LOS ANGELES, UNITED STATES

CYCLIC RGD PEPTIDES WITH HIGH AFFINITY FOR ALPHA5BETA1 INTEGRIN INHIBIT MACROPHAGE RECRUITMENT IN STEATOTIC LIVER ISCHEMIA/REPERFUSION INJURY

Robert Öllinger, INNSBRUCK, AUSTRIA

BILIRUBIN SUPPRESSES NEOINTIMA FORMATION BY INTERACTING WITH THE RETINOBLASTOMA TUMOR SUPPRESSOR PROTEIN PATHWAY

Cecile Braudeau, NANTES, FRANCE

BLOOD CD25+CD4+ T CELLS PHENOTYPE AND REGULATION ASSOCIATED MOLECULES IN "OPERATIONALLY TOLERANT” VERSUS CHRONIC REJECTION HUMAN KIDNEY RECIPIENTS

Supported through an unrestricted educational grand from: Astellas

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada